MultiCell Technologies Inc ( NASDAQ: MCET ) , a biotech firm is granted a patent by US Patent and Trademark Office. Patent is about the isolation and use of human liver stem cells to treat liver disease. Penny Stock soared more than 120 % and might keep going higher. Traders might trade the stock with buy positions at current levels and might get handsome returns. Strong Move Alert, On radar at stockinvestips.
Below is the news fro Reuters:
MultiCell Technologies, Inc. announced the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver disease. Under the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S. patent 7,935,528. The patent describes methods to isolate and use human liver stem cells to treat degenerative liver diseases, or inherited deficiencies of liver function.
0 comments